I hope that some people see some connection between the two topics in the title. If not, anyway, such connections will be developed in the course of these talks. Furthermore, because of the use of tools involvin
i.e., late at the BCT evolution. For Polish (at the end of the 1940s) Zaręba (1954, p. 138) found that elderly speakers did not understand the meaning of BCTsfioletowy‘purple’ andpomarańczowy‘orange’ used by young speakers with high consensus. The ...
i.e., late at the BCT evolution. For Polish (at the end of the 1940s) Zaręba (1954, p. 138) found that elderly speakers did not understand the meaning of BCTsfioletowy‘purple’ andpomarańczowy‘orange’ used by young speakers with high consensus. The ...
Brain Behavior and Evolution 14, 185-216.Naming of neurones - ROWE, STONE - 1977 () Citation Context ...in form and function continues. The drawback of this approach is the necessity to identify the essenc...
The fact that various studies analyzing language ability in children with CIs conclude that those with bilateral CIs perform no better than those with unilateral CIs highlights the need to carefully consider and evaluate the necessity of a second implant in each individual case. However, as we ...
The availability of eight sub-areas allows the application to accomplish a number of functions without the necessity of a translation table lookup and thus speeds input/output operations. However, since any application program may need to have access to all of the input/output assets which are ...
Naming of neurones - ROWE, STONE - 1977 () Citation Context ...in form and function continues. The drawback of this approach is the necessity to identify the essence correctly and therefore delegating any other features as secondary, nonessential, or accidental (=-=Rowe and Stone, 19...
Moreover, a necessity of the go/no-go paradigm is that the number of critical trials across different conditions must be unbalanced to manipulate response biases, which inevitably leads to differences in power across conditions. However, the conditions with fewer critical trials (e.g., go trials...